Ortin Global Ltd
ORTINGLOBEOrtin Global Ltd
ORTINGLOBE
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -2.09 | 5.54 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 50.35 | 6.43 | 0.53% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Ortin Laboratories Limited is engaged in the business of manufacturing and trading of pharmaceuticals, drugs and intermediates.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Mankind Pharma Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 63.52 | 62.20 | 80.16 | 167.89 | 197.58 | 8.22 | 8.42 | 6.06 | 2.28 | 0.71 | ||||||||||
Raw Materials | 45.08 | 38.48 | 56.30 | 141.54 | 165.15 | 4.08 | 4.61 | 3.89 | 2.38 | 6.91 | ||||||||||
| Power & Fuel Cost | 4.68 | 4.75 | 4.10 | 5.67 | 5.39 | 0.11 | 0.22 | 0.24 | 0.17 | |||||||||||
| Employee Cost | 2.13 | 2.59 | 2.78 | 3.68 | 4.72 | 0.85 | 0.74 | 0.68 | 0.48 | |||||||||||
| Selling & Administrative Expenses | 3.30 | 2.53 | 2.23 | 3.42 | 4.71 | 1.06 | 1.42 | 0.72 | 1.31 | |||||||||||
| Operating & Other expenses | 1.87 | 8.08 | 8.91 | 6.77 | 11.73 | 0.82 | 0.87 | 0.00 | 4.30 | |||||||||||
EBITDA | 6.46 | 5.77 | 5.84 | 6.81 | 5.88 | 1.30 | 0.56 | 0.53 | -6.36 | -6.20 | ||||||||||
| Depreciation/Amortization | 1.65 | 1.70 | 1.69 | 1.75 | 1.96 | 0.29 | 0.29 | 0.25 | 0.23 | 0.11 | ||||||||||
| PBIT | 4.81 | 4.07 | 4.15 | 5.06 | 3.92 | 1.01 | 0.27 | 0.28 | -6.59 | -6.31 | ||||||||||
| Interest & Other Items | 3.42 | 2.94 | 3.49 | 3.22 | 3.21 | 0.87 | 0.81 | 0.40 | 0.48 | 0.24 | ||||||||||
| PBT | 1.39 | 1.13 | 0.66 | 1.84 | 0.71 | 0.14 | -0.54 | -0.12 | -7.07 | -6.55 | ||||||||||
| Taxes & Other Items | 0.57 | 0.63 | 0.00 | 0.56 | 1.29 | -0.81 | -0.13 | -0.02 | 0.96 | 0.94 | ||||||||||
| Net Income | 0.82 | 0.50 | 0.66 | 1.28 | -0.58 | 0.95 | -0.41 | -0.10 | -8.03 | -7.49 | ||||||||||
| EPS | 0.48 | 0.30 | 0.39 | 0.76 | -0.34 | 0.76 | -0.50 | -0.12 | -9.88 | -9.21 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Ortin Global Ltd | -1.95 | 5.54 | — |
| Sun Pharmaceutical Industries Ltd | 44.14 | 6.30 | 0.77% |
| Cipla Ltd | 29.25 | 4.50 | 0.87% |
| Torrent Pharmaceuticals Ltd | 65.91 | 15.92 | 0.87% |
Price Comparison
Compare ORTINGLOBE with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
ORTINGLOBE has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 24, 2013
Dividend/Share
₹0.25
Ex DateEx Date
Sep 24, 2013
Cash Dividend
Ex DateEx DateSep 24, 2012
Dividend/Share
₹0.50
Ex DateEx Date
Sep 24, 2012
Cash Dividend
Ex DateEx DateOct 13, 2011
Dividend/Share
₹0.50
Ex DateEx Date
Oct 13, 2011
Cash Dividend
Ex DateEx DateSep 23, 2010
Dividend/Share
₹0.80
Ex DateEx Date
Sep 23, 2010
Net Loss of Ortin Global reported to Rs 0.47 crore in the quarter ended September 2024 as against net loss of Rs 1.12 crore during the previous quarter ended September 2023. Sales declined 80.77% to Rs 0.05 crore in the quarter ended September 2024 as against Rs 0.26 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales0.050.26 -81 OPM %-900.00-342.31 - PBDT-0.47-1.04 55 PBT-0.47-1.10 57 NP-0.47-1.12 58 Powered by Capital Market - Live
Ortin Global will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live
Ortin Laboratories announced that the 37th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
Net loss of Ortin Laboratories reported to Rs 0.10 crore in the quarter ended June 2024 as against net profit of Rs 0.02 crore during the previous quarter ended June 2023. Sales declined 86.62% to Rs 0.21 crore in the quarter ended June 2024 as against Rs 1.57 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales0.211.57 -87 OPM %-47.6212.10 - PBDT-0.100.08 PL PBT-0.100.02 PL NP-0.100.02 PL Powered by Capital Market - Live
Ortin Laboratories will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live
Ortin Laboratories will hold a meeting of the Board of Directors of the Company on 31 July 2024.Powered by Capital Market - Live
Ortin Laboratories reports standalone net profit of Rs 0.46 crore in the December 2022 quarter
Ortin Laboratories Ltd leads gainers in ‘B’ group
Ansal Housing Ltd leads gainers in ‘B’ group
Bhartiya International Ltd leads gainers in ‘B’ group
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of -57.68%, vs industry avg of 9.03%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.08% to 0%